Keyphrases
Molecular Mechanism
100%
Soft Tissue Sarcoma
100%
DNA Damage Response Pathway
42%
Cancer Predisposition Genes
28%
Genetic Defects
28%
Biochemical Phenotyping
14%
Appropriate Testing
14%
High-penetrance Genes
14%
In Vitro Drug Screening
14%
Clinical Phenotyping
14%
Cancer Subtypes
14%
Sarcoma
14%
Clinical Utility
14%
Next-generation Sequencing Technology
14%
Pathogenic Germline mutation
14%
New Genetics
14%
Premature Mortality
14%
Genetic Predisposition
14%
Germline mutation
14%
Rare Cancer
14%
Tumor Predisposition
14%
Next-generation Sequencing
14%
Pathway Genes
14%
Tumorigenesis
14%
Cancer Predisposition
14%
Clinical Validity
14%
Predisposition Genes
14%
Cancer Risk
14%
Genetic Risk
14%
Clinically Significant
14%
Developed Countries
14%
Clinical Actionability
14%
Genetic Approach
14%
Related Technology
14%
Biochemistry, Genetics and Molecular Biology
DNA Repair
100%
Genetics
100%
Germline Mutation
66%
Next Generation Sequencing
66%
Genetic Risk
33%
Drug Screening
33%
Premature Mortality
33%
Genetic Predisposition
33%
Genetic Approach
33%
Penetrance
33%
Carcinogenesis
33%